<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Early Clinical Trials With Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information; Guidance for Industry; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Early Clinical Trials With Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information; Guidance for Industry; Request for Comments</h1>
    <p class="timestamp">Published: 2015-03-31 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing a request for additional comments on the chemistry, manufacturing, and control (CMC) information that a sponsor of an investigational new drug application (IND) should provide in its IND in order to meet regulatory requirements when commercially available foods or dietary supplements containing live biotherapeutic products (LBPs) are used as investigational new drugs in early phase clinical trials. The request for additional comments on the CM...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2015-07273</p>
    <p><strong>Publication Date:</strong> 2015-03-31</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2015/03/31/2015-07273/early-clinical-trials-with-live-biotherapeutic-products-chemistry-manufacturing-and-control">https://www.federalregister.gov/documents/2015/03/31/2015-07273/early-clinical-trials-with-live-biotherapeutic-products-chemistry-manufacturing-and-control</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2015-07273</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
